Insmed
INSM
#677
Rank
A$50.80 B
Marketcap
A$235.71
Share price
-1.47%
Change (1 day)
104.01%
Change (1 year)

Insmed (INSM) - Total debt

Total debt on the balance sheet as of December 2025 : A$0.85 Billion

According to Insmed's latest financial reports the company's total debt is A$0.85 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Insmed - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2025-12-31A$0.87 B-52.58%
2024-12-31A$1.84 B4.52%
2023-12-31A$1.76 B2.1%
2022-12-31A$1.73 B104.95%
2021-12-31A$0.84 B60.4%
2020-12-31A$0.52 B-7.16%
2019-12-31A$0.56 B26.2%
2018-12-31A$0.44 B531.33%
2017-12-31A$71.17 M-6.36%
2016-12-31A$76.01 M120.26%
2015-12-31A$34.5 M13.63%
2014-12-31A$30.37 M37.62%
2013-12-31A$22.06 M18.29%
2012-12-31A$18.65 M6731.99%
2011-12-31A$0.27 M69.14%
2010-12-31A$0.16 M-30.27%
2009-12-31A$0.23 M-92.23%
2008-12-31A$2.97 M-22.8%
2007-12-31A$3.85 M-3.76%
2006-12-31A$4 M-54.42%
2005-12-31A$8.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Novartis
NVS
A$51.33 B 5,929.96%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
A$36.18 B 4,150.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$2.94 B 246.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$1.50 B 77.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A$0.48 B-42.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
A$1.11 B 30.60%๐Ÿ‡บ๐Ÿ‡ธ USA